Knockout Mouse Catalog | Cyagen APAC
Cyagen Coronavirus Update COVID-19
Cytokine Storm: The New Perspective for COVID-19 Research
Since COVID-19 poses a significant threat to public health and also represents a challenge for antiviral drug development and administration globally, current efforts focus on prevention and control while accelerating the research on the SARS-CoV-2 coronavirus, which has caused the outbreak of COVID-19. So far, studies on the epidemiological and clinical characteristics of this illness is still growing, but there is significant anecdotal evidence of value. Read More ›
Cyagen Coronavirus Update Research Trends Newsletter COVID-19
Researching the New Coronavirus, SARS-CoV-2: Applications for Animal Models
The novel coronavirus, now officially designated as SARS-CoV-2, was first identified in Wuhan, Hubei Province, China in December of 2019. This virus has led to an outbreak of COVID-19 (Coronavirus Disease in 2019), which is associated with acute respiratory illness and infection, as is common for diseases caused by the coronavirus family. Read More ›